Otitis media: Re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity

Pediatric Clinics of North America

Volumn 52, Issue 3, 2005, Pages 711-728

  Pelton, Stephen I ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c Maxwell Finland Lab Infect Dis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFDINIR; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; INFLUENZA VACCINE; MACROLIDE; OFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; SULFONAMIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; CONJUNCTIVITIS; DISEASE SEVERITY; DRUG CHOICE; HUMAN; IMMUNIZATION; INSTRUMENT STERILIZATION; MEDICAL ASSESSMENT; OTITIS MEDIA; REVIEW; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ALGORITHMS; ANTI-BACTERIAL AGENTS; CHILD; COMORBIDITY; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE EAR VENTILATION; MORBIDITY; OTITIS MEDIA; PEDIATRICS; PNEUMOCOCCAL VACCINES; PRACTICE GUIDELINES; PRIMARY PREVENTION; RECURRENCE; RISK FACTORS; SEROTYPING; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VACCINATION; VACCINES, CONJUGATE;

EID: 19544384936     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2005.02.013     Document Type: Review

References (64)

1. J. Eskola, T. Kilpi, and A. Palmu Efficacy of a pneumococcal conjugate vaccine against acute otitis media N Engl J Med 344 2001 403 409
2. M.C. McEllistrem, J. Adams, E.O. Mason, and E.R. Wald Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine J Infect Dis 188 2003 1679 1684
3. S.I. Pelton, A. Loughlin, and C.D. Marchant Seven valent pneumococcal vaccine immunization in two Boston communities: changes in serotypes distribution and antimicrobial susceptibility among Streptococcus pneumoniae isolates Pediatr Infect Dis J 23 2004 1015 1022
4. F. Ghaffar, T. Barton, and J. Lozano Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first two years of life Clin Infect Dis 39 7 2004 930 938
5. S.L. Block, J. Hecrick, and C.J. Harrison Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media Pediatr Infect Dis J 23 2004 829 833
6. J.R. Casey, and M.E. Pickickero Change in frequency and pathogens causing acute otitis media in 1995-2003 Pediatr Infect Dis J 23 2004 824 828
7. N. Porat, G. Barkai, M.R. Jacobs, R. Trefler, and R. Dagan Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel J Infect Dis 189 2004 385 392
8. E. Leibovitz, D. Greenberg, and L. Piglansky Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen Pediatr Infect Dis J 22 2003 209 215
9. Leibovitz E., Libson S., Greenberg D., Porat N., Leiberman A., Dagan R. The presence of Streptococcus pneumoniae (Pnc) in nasopharynx (NP) after successful treatment of acute otitis media (AOM) predicts its etiologic role in the next AOM episode. Abstract No. G-1855-2003. Presented at 44th ICAAC. Washington, DC, October 30, 2004
10. J.A. Finkelstein, C. Stille, and J. Nordin Reduction in antibiotic use among US children 1999-2000 Pediatrics 112 2003 620 627
11. S.I. Pelton Otoscopy for the diagnosis of otitis media Pediatr Infect Dis J 17 1998 540 543
12. K. Blomgren, S. Pohjavuori, T. Poussa, K. Hatakka, R. Korpela, and A. Pitkaranta Effect of accurate diagnostic criteria on incidence of acute otitis media in otitis-prone children Scand J Infect Dis 36 2004 6 9
13. M.E. Pichichero, and M.D. Poole Assessing diagnostic accuracy and tympanocentesis skill in the management of otitis media Arch Pediatr Adolesc Med 155 2001 P1137 P1142
14. E. Leibovitz, R. Satran, and L. Piglansky Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae? Pediatr Infect Dis J 22 2003 509 514
15. W.J. Rodriguez, and R.H. Schwartz Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis Pediatr Infect Dis J 18 1999 942 944
16. A.A. Palmu, E. Herva, H. Savolainen, P. Karma, P.H. Makela, and T.M. Kilpi Association of clinical signs and symptoms with bacterial findings in acute otitis media Clin Infect Dis 38 2004 234 242
17. R. Dagan, E. Leibovitz, and D. Greenberg Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome Pediatr Infect Dis J 17 1998 776 782
18. E.F. Bodor Conjunctivitis-otitis syndrome Pediatrics 69 1982 695 698
19. I.J.M. Dhooge, F.W.J. Albers, and P.B. Van Cauwenberge Intratemporal and intracranial complications of acute suppurative otitis media in children: renewed interest Int J Pediatr Otorhinolaryngol 49 1999 S109 S114
20. R.S. Bahadori, R.H. Schwartz, and M. Ziai Acute mastoiditis in children: an increase in frequency Northern Virginia Pediatr Infect Dis J 19 2000 212 215
21. F.A. Ghaffar, M. Wördemann, and H. McCracken Jr Acute mastoiditis in children: a seventeen-year experience in Dallas, Texas Pediatr Infect Dis J 20 2001 376 380
22. K. Leskinen, and J. Jero Complication of acute otitis media in children in southern Finland Int J Pediatr Otorhinolaryngol 68 2004 317 324
23. D.S. Kacmarynski, S.C. Levine, S.E. Pearson, and R.H. Maisel Complications of otitis media before placement of tympanostomy tubes in children Arch Otolaryngol Head Neck Surg 103 2004 289 292
24. P.H. Kaleida, M.L. Casselbrant, and H.E. Rockette Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial Pediatrics 87 1991 466 474
25. P. Little, C. Gould, I. Williamson, M. Moore, G. Warner, and J. Dunleavey Pragmatic randomized controlled trial of two prescribing strategies for childhood acute otitis media BMJ 322 2001 336 342
26. R.A.M.J. Damoiseaux, F.A.M. van Balen, and A.W. Hoes Primary care based randomized double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years BMJ 320 2000 350 354
27. McCormick D.P., Chonmaitree T., Pittman C., et al. Non-severe acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Presented at the Pediatric Academic Society, San Francisco, 2004
28. A.S. Lieberthal, T.G. Ganiates, and E.O. Cox Clinical practice guidelines: diagnosis and treatment of acute otitis media Pediatrics 113 2004 1451 1465
29. U.B. Schaad Correlation between bacteriologic eradication and clinical cure in acute otitis media Pediatr Infect Dis J 23 2004 281 282
30. R. Dagan Correlation between bacteriologic eradication and clinical cure in acute otitis media: in reply Pediatr Infect Dis J 23 2004 281 282
31. R. Dagan, E. Leibovitz, D. Greenberg, P. Yagupsky, D.M. Fliss, and A. Leiberman Early eradication of pathogens from middle ear fluid during antibacterial agent treatment of acute otitis media is associated with improved clinical outcome Pediatr Infect Dis J 17 1998 776 782
32. L. Piglansky, E. Leibovitz, and S. Raiz Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children Pediatr Infect J 22 2003 405 412
33. E. Leibovitz, L. Piglanksky, and S. Raiz Bacteriological and clinical efficacy of oral gatifloxacinin the treatment of recurrent/non-responsive acute otitis media: an open label, single center, non-comparative, double tympanocentesis study Pediatr Infect Dis J 22 2003 1 7
34. S.A. Carlin, C.D. Marchant, P.A. Shurin, C.E. Johnson, and D.M. Super Host factors and early therapeutic response in acute otitis media J Pediatr 118 1991 178 183
35. A. Leiberman, E. Leibovitz, and L. Piglansky Bacteriologic and clinical efficacy of TMP/SMX for the treatment of AOM Pediatr Infect Dis J 20 2001 260 264
36. R.M. Rosenfeld, J.E. Vertrees, and J. Carr Clinical efficacy of antibacterial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials J Pediatr 124 1994 355 367
37. R.M. Rosenfeld, and D. Kay Natural history of untreated otitis media R.M. Rosenfeld C.D. Bluestone Evidence-based otitis media 2003 Decker Hamilton, Ontario 180 198
38. S.F. Dowell, J.C. Butler, and S.G. Giebink The Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group Pediatr Infect Dis J 18 1999 1 9
39. S.F. Dowell, S.M. Marcy, W.R. Phillips, M.A. Gerber, and B. Schwartz Otitis media-principles of judicious use of antimicrobial agents Pediatrics 101 1998 165 171
40. P. Little, C. Gould, M. Moore, G. Warner, J. Dunleavey, and I. Williamson Predictors of poor outcome and benefits from antibacterial agents in children with acute otitis media: pragmatic randomized trial BMJ 325 2002 22
41. W. Craig Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men Clin Infect Dis 26 1998 1 12
42. M.R. Jacobs Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters Pediatr Infect Dis J 19 2000 S47 S55
43. R. Dagan, A. Hoberman, and C. Johnson Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media Pediatr Infect Dis J 20 2001 829 837
44. R. Dagan, E. Leibovitz, and D.M. Fliss Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children Antimicrob Agents Chemother 44 2000 43 50
45. L. Bertin, G. Pons, and P. d'Athis A randomized, double-blind, multicenter controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children Fundam Clin Pharmacol 10 1996 387 392
46. A. Hoberman, J.L. Paradise, E.A. Reynolds, and J. Urkin Efficacy of auralgan for treating ear pain in children with acute otitis media Arch Pediatr Adolesc Med 151 1997 675 678
47. E. Leibovitz, L. Piglansky, S. Raiz, J. Press, A. Leiberman, and R. Dagan Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children Pediatr Infect Dis J 19 2000 1040 1045
48. A. Ruohola, T. Heikkinen, O. Meurman, T. Puhakka, N. Lindblad, and O. Ruuskanen Antibiotic treatment of acute otorrhea through tympanostomy tube: randomized double-blind placebo-controlled study with daily follow- up Pediatrics 111 2003 1061 1067
49. P.S. Roland, J.E. Dohar, and B.J. Lanier Topical ciproflaxacin/ dexamethosone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes Otolaryngol Head Neck Surg 130 2004 736 741
50. J.E. Dohar, E.T. Garner, and R.W. Nielsen Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes Arch Otolaryngol Head Neck Surg 125 1999 537 545
51. J.H. Hwang, H.Y. Tsai, and T.C. Liu Community-acquired methicillin-resistant Staphylococcus aureus infections in discharging ears Acta Otolyaryngol 122 2002 827 830
52. J.L. Paradise, H.M. Feldman, and T.F. Campbell Early versus delayed insertion of tympanostomy tubes for persistent otitis media: developmental outcomes at the age of three years in relation to prerandomization illness patterns and hearing levels Pediatr Infect Dis J 22 2003 309 314
53. J. Roberts, L. Hunter, and J. Gravel Otitis media, hearing loss and language learning: controversies and current research Dev Behav Pediatr 25 2004 110 122
54. J.E. Roberts, R.M. Rosenfeld, and S.A. Zeisel Otitis media and speech and language: a meta-analysis of prospective studies Pediatrics 113 2004 e238 e248
55. R.M. Rosenfeld, L. Culpepper, and K.J. Doyle Clinical practice guideline: otitis media with effusion Otolaryngol Head Neck Surg 130 2004 s95 s118
56. K.A. Daly, M.L. Casselbrant, and H.J. Hoffman Epidemiology, natural history and risk factors Ann Otol Rhinolaryngol 111 2002 19 25
57. K.A. Daly, and G.S. Giebink Clinical epidemiology of otitis media Pediatr Infect Dis J 19 Suppl 5 2000 S31 S36
58. M.L. Casselbrant, P.H. Kaleida, H.E. Rockette, J.L. Paradise, C.D. Bluestone, and M. Kurs-Lasky Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial Pediatr Infect Dis J 11 1992 278 286
59. R.L. Williams, T.C. Chalmers, K.C. Stange, F.T. Chalmers, and S.J. Bowlin Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion: a meta-analytic attempt to resolve the brouhaha JAMA 270 1993 1344 1351
60. D.A. Clements, L. Langdon, and C. Bland Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care Arch Pediatr Adolesc Med 149 1995 1113 1117
61. R.B. Belshe, and W.C. Gruber Prevention of otitis media in children with live attenuated influenza vaccine given intranasally Pediatr Infect Dis J 19 Suppl 5 2000 S66 S71
62. A. Hoberman, D.P. Greenberg, and J.L. Paradise Efficacy of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial JAMA 290 2003 1608 1616
63. B. Fireman, S.B. Black, H.R. Shinefield, J. Lee, E. Lewis, and P. Ray Impact of the pneumococcal conjugate vaccine on otitis media Pediatr Infect Dis J 22 2003 10 16
64. R. Veenhoiven, D. Bogaert, and C. Uiterwaal Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomized study Lancet 361 2003 2189 2195